Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HETEROLEPTIC CYCLOPENTADIENYL TRANSITION METAL PRECURSORS FOR DEPOSITION OF TRANSITION METAL-CONTAINING FILMS
Document Type and Number:
WIPO Patent Application WO/2010/010538
Kind Code:
A2
Abstract:
Methods and compositions for depositing a film on one or more substrates inciude providing a reactor with at least one substrate disposed in the reactor. At least one metal precursor are provided and at least partially deposited onto the substrate to form a metal-containing film. Methods for forming heteroleptic amidinate or guanidinate cydopentadieny! containing transition metal precursors through synthesis reactions are also included.

Inventors:
DUSSARRAT CHRISTIAN (US)
LANSALOT-MATRAS CLEMENT (US)
Application Number:
PCT/IB2009/053252
Publication Date:
January 28, 2010
Filing Date:
July 24, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AIR LIQUIDE (FR)
DUSSARRAT CHRISTIAN (US)
LANSALOT-MATRAS CLEMENT (US)
International Classes:
C23C16/18; C07F17/02
Domestic Patent References:
WO2008088563A22008-07-24
WO2009013721A12009-01-29
Foreign References:
US20080102205A12008-05-01
US20050042372A12005-02-24
Other References:
YAMAGUCHI, YOSHITAKA ET AL: "(.eta.5-C5Me5)Ru( amidinate ): Highly Reactive Ruthenium Complexes Formally Bearing 16 Valence Electrons Showing Signs of Coordinative Unsaturation" ORGANOMETALLICS , 19(5), 725-727 CODEN: ORGND7; ISSN: 0276-7333, 2000, XP002561986
Download PDF:
Claims:
What is claimed is

1 A method of forming a metal containing film on a substrate, comprising a) providing a reactor and at least one substrate disposed therein, b) introducing a metal containing precursor into the reactor, wherein the metal containing precursor comprises a precursor of the general formula

M(RrN-C(R2)=N-R3)n{R4R5R6R7R8Cp)mLk (I) wherein

M is at least one member selected from the group consisting of Mn, Fe, Ni, Co, Cu, Pd, Pt, Ag, Au, Ru, Os, Rh, Ir, and Re,

- (R1-N-C(R2)^N-R3) is an amidine or guanidine hgand, - (R4RsReRyRsCp) is a, substituted or unsubstituted, cyclopentadienyl ligand,

Ri , R3, R4, R5, Re, R7, and Rg are independently selected from H, a C1 -C5 aikyl group, and Si(R )3 where R' is independently selected from H, and a C1 -C5 alkyl group, - R2 is independently selected from H, a C1-C5 alkyi group, and NR R", where R' and R' are independently selected from C1 -C5 alkyl groups, L is a neutra! hgand,

- 1 < m ≤ 4, - 1 < n ≤ 4, and

- 0 < k ≤ 5, c) maintaining the reactor at a temperature of at least 1000C, and d) contacting the precursor with the substrate to form a metal containing film

2 The method of claim 1 , wherein the metal containing precursor comprises a precursor of the general formula M(R1-N-C(R2)=N-R3)n(R4R5R6R7R8Cp)mLk (I) wherein:

- M is at least one member selected from the group consisting of Ni, Co, and Ru, - (RrN-C(R2J=N-R3) is bis isopropylacetamidinate, wherein R1 = R3

= isopropyl and R2 = methyi;

- (R4RsReRyRsCp) is either methylcyclopentadienyl, wherein R4 = Me and R5 = R6 = R7 = H; or tetramethylcyclopentadienyl, wherein R4 = H and R5 = R6 = R7 =Rs = Me, - m = n = 1 , and

- k = 0

3 The method of claim 1 , further comprising maintaining the reactor at a temperature between about 1000C to about 5000C

4 The method of claim 3, further comprising maintaining the reactor at a temperature between about 1500C and about 3500C

5 The method of claim 1 , further comprising maintaining the reactor at a pressure between about 1 Pa and about 105 Pa

6 The method of claim 5, further comprising maintaining the reactor at a pressure between about 25 Pa and about 103 Pa

7 The method of claim 1 , further comprising introducing at least one reducing gas into the reactor, wherein the reducing gas comprises at least one member selected from the group consisting of H2, NH3, SiH4, Si2H6, Si3H8, SiH2Me2, SiH2Et2, N(SιH3)3, hydrogen radicals, and mixtures thereof

8 The method of claim 7, wherein the metal containing precursor and the reducing gas are introduced into the chamber substantially simultaneously, and the chamber is configured for chemical vapor deposition

9. The method of claim 7, wherein the metal containing precursor and the reducing gas are introduced into the chamber substantially simultaneously, and the chamber is configured for plasma enhanced chemical vapor deposition.

10. The method of claim 7, wherein the metal containing precursor and the reducing gas are introduced into the chamber sequentially, and the chamber is configured for atomic layer deposition.

1 1 The method of ciaim 7, wherein the metal containing precursor and the reducing gas are introduced into the chamber sequentially, and the chamber is configured for plasma enhanced atomic layer deposition

12. The method of claim 1 , further comprising introducing at least one oxidizing gas into the reactor, wherein the oxidizing gas comprises at least one member selected from the group consisting of: O2, O3; H2O; NO; oxygen radicals, and mixtures thereof.

13. The method of claim 12, wherein the metal containing precursor and the oxidizing gas are introduced into the chamber substantially simultaneously, and the chamber is configured for chemical vapor deposition.

14 The method of claim 12, wherein the metal containing precursor and the oxidizing gas are introduced into the chamber substantially simultaneously, and the chamber is configured for plasma enhanced chemical vapor deposition.

1 5. The method of claim 12, wherein the first metal containing precursor and the oxidizing gas are introduced into the chamber sequentially, and the chamber is configured for atomic layer deposition

16. The method of claim 12, wherein the first metal containing precursor and the oxidizing gas are introduced into the chamber sequentially, and the chamber is configured for plasma enhanced atomic layer deposition.

17. The method of claim 1 , wherein the metal containing precursor comprises at least one member selected from the group consisting of: (cyc!opentadienyS)-(bis-isopropy!acetamιdιnate)-nickel; (methyicyclopentadienyl)-(bis-isopropylacetamidinate)-nickel; (ethylcyclopentadienyl)-(bis-isopropylacetamidιnate)-nιckel; (isopropylcyclopentadienyl)-(bis-isopropylacetamidinate)-nickel;

(tetramethylcyclopentadιenyl)-(bis-ιsopropylacetamιdinate)-nιcke!; (cyc!opentadienyl)-(methyl-isopropylacetamidιnate)-nickel, (methylcyclopentadιenyl)-(methyl-isopropyiacetamidιnate)-nickel; (ethylcyclopentadienyi)-(methyl-isopropylcetamidinate)-nickel; (cyclopentadienyl)-(methyl-ethylacetamιdinate)-nιckel;

(methylcyclopentadienylHmethyl-ethylacetamidinate)-nickel, (ethylcyclopentadιenyl)-(methyl-ethylacetamidιnate)-nιckel, (cyclopentadienyiHbis-isopropylformamidinate^rnckel; (methylcyclopentadienyl)-(bιs-isopropylformamιdιnate)-nιckel, and (ethylcyclopentadienylHbis-isopropylformamidinateJ-ntckef.

1 δ. The method of claim 1 , wherein the metal containing precursor comprises at least one member selected from the group consisting of: (cyclopentadιeny!)-{bis-ιsopropylacetamidιnate)-coba!t, (methylcyclopentadιenyi)-(bιs-ιsopropylacetamιdιnate)-cobalt,

(ethylcyclopentadιenyl)"{bfs-isopropyiacetamιdιnate)-cobalt; (ιsopropylcyclopentadienyl)-{bis-isopropylacetamidιnate)-cobalt; (tetramethylcyc!opentadιenyl)-(bιs~ιsopropylacetamιdιnate)-cobaSt, (cyclopentadienyi)-{methyl-isopropy!acetamidinate)-cobalt; (methylcyclopentadienyl)-(methyl-ιsopropylacetamιdιnate)-cobalt,

(ethylcyclopentadιenyl)-{methyl-isopropylcetamιdsnate)-coba!t, (cyclopentadιenyl)-{methyl-ethyiacetamιdιnate)-cobalt; (methylcyclopentadιenyl)-(methy[-ethylacetamιdιnate)-cobait, (ethyScyciopentadienyl)-(methyi-ethySacetamidinate)-cobalt, (cyclopentadienylHbiSHSopropylformamidinateJ-cobait, (methylcyclopentadienylj-fbis-isopropylformamidinatej-cobalt, and (ethylcyciopentadienylHbis-isopropylformamidfnate^cobalt

19 The method of claim 1 , wherein the metal containing precursor comprises at ieast one member selected from the group consisting of (cyclopentadienytHbis-isopropylacetamtdinateJ-ruthenium, (methylcyclopentadienylHbis-isopropylacetamidinateJ-ruthenium,

(θthyicyclopentadιenyi)-(bιs-ιsopropyiacetamιdιnate)-ruthenium, (isopropyicyciopentadienylHbisHsopropylacetamidinateJ-ruthenium, (tetramethylcyciopentadienyO^bis-isopropylacetamidinate^ruthenium, (cydopentadienylHrnethyl-isopropylacetamidinateJ-ruthenium, (methylcydopentadienylHmethyl-isopropylacetamidinateJ-ruthenium,

(ethylcyclopentadienylHrnethyl-isopropylcetamidinateJ-ruthenium, (cyclopentadienyiHmethyl-ethyiacetamidinateJ-ruthenium, (methylcyclopentadienySHmethyl-ethylacetamidmateJ-ruthenium, (ethylcyclopentadienylHmethyl-ethylacetamidmateJ-ruthenium, (cyclopentadienylHbis-isopropylformamidinateHuthenium,

(methylcyclopentadienyi)-(bis-isopropyiformamidinate)-ruthenium, and (ethylcyclopentadienylj-fbis-isopropylformamidinatej-ruthenium

20 A method of synthesizing a heteroieptic cyclopentadieny! transition metal precursor, comprising performing at least one reaction to form a metal containing precursor, wherein the metal containing precursor comprises a precursor of the general formula

M(R1-N-C(R2)=N-R3)n{R4R5R6R7R8Cp)mLκ (I) wherein - M is at least one member selected from the group consisting of

Mn, Fe, Ni, Co, Cu, Pd, Pt, Ag, Au, Ru Os, Rh, Ir, and Re, - (R1-N-C(Ra)=N-R3) is an amidsne or guanidine hgand, (R4RsReRyReCp) is a, substituted or unsubstituted, cyclopentadienyl iigand;

R-I, R3, R4, R5, Re, R7, and R8 are independently selected from H; a

C1 -C5 alky! group; and Si(R')3, where R' is independently selected from H, and a C1-C5 alkyl group;

R2 is independently selected from H; a C1-C5 aikyl group; and

NR1R", where R' and R" are independently selected from C1-C5 alkyl groups;

L is a neutral Iigand;

1 ≤ m ≤ 4;

1 ≤ n ≤ 4; and

0 ≤ k < 5.

21. The method of claim 20, wherein the precursor is formed according to the synthesis reaction:

wherein:

M is at least one member selected from the group consisting of: Mn; Fe; Ni; Co; Cu; Pd; Pt; Ag; Au; Ru; Os; Rh; Ir; and Re; (R1-N-C(R2J-N-R3) is an amidine or guanidine Iigand; (R4R5ReRyRsCp) is a, substituted or unsubstituted, cyclopentadienyl Iigand;

Ri, R3, R4, R5, Re, R7, and R8 are independently selected from H; a C1-C5 alkyl group; and Si(R!)3 where R' is independently selected from H, and a C1 -C5 alkyl group; - R2 is independently selected from H; a C1-C5 alky! group; and NR'R", where R' and R" are independently selected from C1 -C5 aikyi groups;

- X is independently selected from Cl; Br; and i; - N is independently selected from Li; Na; and K;

- L and Q are neutrai ϋgands;

- 1 < m < 4;

- 1 ≤ n < 4;

- 0 < k < 5; - 0 ≤ j ≤ 5; and

- 0 < p < 5.

22. The method of claim 20, wherein the precursor is formed according to the synthesis reaction: Scheme-2-1

wherein:

M is at least one member selected from the group consisting of: Mn; Fe; Ni; Co; Cu; Pd; Pt; Ag; Au; Ru; Os; Rh; Ir; and Re; (R1-N-C(R2J=N-R3) is an amidine or guanidine ligand; - (R4R5R6R7R8CP) is a, substituted or unsubstituted, cyciopentadienyl ligand;

R3, R4, R5, Re, R7, and R8 are independently selected from H; a C1-C5 alkyl group; and Si(R'}3 where R' is independently selected from H, and a C1-C5 alkyl group; - R2 is independently selected from H, a C1-C5 a!kyi group; and NR'R", where R' and R" are independently selected from C1-C5 aikyi groups,

- N is independently selected from H, Li, Na, and K, L is a neutral hgand,

- 1 < m < 4,

- 1 < n < 4, and

- O ≤ k < 5

23 The method of claim 20, wherein the precursor is formed according to the synthesis reaction Scheme-2-2

wherein

- M is at least one member selected from the group consisting of Mn, Fe, Ni, Co, Cu, Pd1 Pt, Ag, Au, Ru, Os, Rh, Ir1 and Re,

- (R1-N-C(R2)^N-R3) is an amidsne or guanidme hgand,

- (R4R5R6RyRsCp) is a, substituted or unsubstituted, cyclopentadienyl Itgand,

- R1 , R3, R4, R5, R6, R7, and R8 are independently selected from H1 a C1 -C5 alkyl group, and Sι(R')3 where R' is independently selected from H, and a C1 -C5 alkyl group;

- R2 is independently selected from H, a C1 -C5 alkyl group, and NR1R", where R' and R" are independently selected from C1 -C5 alkyl groups, N is independently selected from H1 Li, Na, and K,

- L is a neutral iigand,

- 1 < m < 4. 1 ≤ n ≤ 4; and 0<k<5.

24. The method of claim 20, wherein the precursor is formed according to the synthesis reaction:

Scheme-3-1

wherein:

M is at least one member selected from the group consisting of:

Mn; Fe; Ni; Co; Cu; Pd; Pt; Ag; Au; Ru; Os; Rh; Ir; and Re;

(R1-N-C(R2J=N-R3) is an amidine or guanidine ligand;

(R4R5R6RyRsCp) is a, substituted or unsubstituted, cyciopentadienyl ligand;

Ri1 R3, R4, R5, R6, Ry, and R8 are independently selected from H; a

C1-C5 aikyl group; and Si(R')3 where R1 is independently selected from H, and a C1-C5 alkyl group;

R2 is independently selected from H; a C1-C5 alkyl group; and

NR1R", where R' and R" are independently selected from C1-C5 alkyl groups;

X is independently selected from Ci; Br; and I;

N is independently selected from Li; Na; and K;

L and Q are neutrai ligands;

1 <m<4;

1 < n<4;

0<k<5;

O≤j ≤ 5; and

0≤p<5. Scheme-3-2

π

wherein:

M is at least one member selected from the group consisting of:

Mn; Fe; Ni; Co; Cu; Pd; Pt; Ag; Au; Ru; Os; Rh; Ir; and Re;

(Ri-N-C(R2)=N-R3) is an amidine or guanidine ligand;

(R4R5ReRyRsCp) is a, substituted or unsubstituted, cyclopentadienyl ligand;

R-I1R3, R4, R5, Re, R?, and R8 are independently selected from H; a

C1-C5 alkyl group; and Si(R')3, where R' is independently selected from H, and a C1-C5 aSkyl group;

R2 is independently selected from H; a C1-C5 alky! group; and

NR1R", where R' and R" are independently selected from C1 -C5 alkyi groups;

X is independently selected from Cl; Br; and I;

N is independently selected from Li; Na; and K;

L and Q are neutral ligands;

1 ≤ m < 4;

1 ≤ n < 4;

0 ≤ k < 5;

O ≤ j ≤ 5; and

0 ≤ p < 5.

Description:
HETEROLEPTIC CYCLOPENTADIENYL TRANSITION METAL PRECURSORS FOR DEPOSITION OF TRANSITION METAL-

CONTAINING FILMS

Background

Fieid of the Invention

This invention relates generally to compositions, methods and apparatus used for use in the manufacture of semiconductor, photovoltaic,

LCF-TFT, or flat panel type devices.

Background of the Invention

During the fabrication of a transistor, silicide layers may be used to improve the conductivity of polysilicon. For instance nickel suicide (NiSi) may be used as a contact in the source and drain of the transistor to improve conductivity. The process to form metal silicide begins by the deposition of a thin transition metal layer, nickel for instance, on the polysiiicon. The metal and a portion of the polysiϋcon are then alloyed together to form the meta! silicide layer.

Chemical Vapor Deposition (CVD) and Atomic Layer Deposition (ALD) are the main gas phase chemica! process used to control deposition at the atomic scale and create extremely thin coatings. In a typical CVD process, the wafer is exposed to one or more volatile precursors, which react and/or decompose on the substrate surface to produce the desired deposit. ALD process are based on sequential and saturating surface reactions of alternatively applied metal precursor, separated by inert gas purging.

In order to get high-purity, thin and high-performance solid materials on the wafer, metal precursors with high purity, high thermal stability and high volatility are required. Furthermore, they should vaporize rapidly and at a reproducible rate, a condition which is more easily achieved for liquid precursors, than it is for solid precursors. Some amidinate transition metal precursors are and have been successfully used for deposition by ALD Although volatile, those precursors are usually solids with high melting point (>70 0 C) and can suffer some time from thermal instability (nickel for instance), which is a drawback for the ALD process. On the other hand, bis-cyclopentadienyl precursors are known to be liquid or low melting point solid, and still volatile depending on the substitution on the cyclopentadienyl For instance, Ni(Me-Cp) 2 solid mp=34-36 0 C, Ni(Et- Cp) 2 liquid, N ι( 1Pr-Cp) 2 liquid However bis-cyclopentadienyl precursors still suffer from thermal instability, with nicke! for instance Consequently there exists a need for new transition metal precursors suitable for CVD or ALD process

Brief Summary

Embodiments of the present invention provide novel methods and compositions useful for the deposition of a film on a substrate In genera!, the disclosed compositions and methods utilize a heteroleptic meta! precursor

In an embodiment a method for depositing a film on a substrate comprises providing a reactor with at least one substrate disposed in the reactor A metal containing precursor is introduced into the reactor, wherein the precursor has the genera! formula

M(Ri-N-C(R 2 )=N-R 3 )π(R 4 R5R6R7R8Cp) m L kl wheresn IvI is a metal selected from among the elements Mn, Fe, Ni, Co, Pd, Pt, Ag, Au, Ru, Os, Rh, Ir, and Re (R 1 -N-C(R 2 J=N-R 3 ) is an amidine or guanidine hgand, and (R 4 R 5 R 6 R 7 R 8 Cp) is a, substituted or unsubstituted, cyclopentadienyl hgand Each of R 1 , R 3 , R 4 , R 5 R 6 , R 7 , and R 8 are independently selected from H, a C1 -C5 alkyl group, and Si(R ) 3 where R is independently selected from H, and a C1-C5 alkyl group R 2 is independently selected from H, a C1 -C5 alkyl group, and NR 1 R", where R' and R" are independently selected from C1 -C5 alky! groups L is a neutral hgand (e g

THF, diethylether, tπglyme, tetragiyme, etc) The variable m is one of 1 , 2, 3, or 4, the variable n is one of 1 ,2,3, or 4, and the variable k is one of 0,1 , 2, 3, 4, or 5 The reactor is maintained at a temperature of at least about 100 0 C, and the precursor is contacted with the substrate to deposit or form a metai containing film on the substrate

In an embodiment, a heteroieptic cyclopentadienyl transition metal precursor is synthesized through at least one synthesis reaction The precursor has the genera! formula

M(R 1 -N-C(R 2 )=N-R 3 ) n (R4R 5 R6R7R 8 Cp) m L k , wherein M is a metai selected from among the eiements Mn, Fe, Ni, Co, Pd, Pt 1 Ag, Au, Ru, Os, Rh, Ir, and Re (RrN-C(R 2 )=N-R 3 ) is an amidine or guanidine hgand, and (R 4 R 5 R 6 RyRsCp) is a, substituted or unsubstituted, cyclopentadienyl hgand Each of R 1 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are independently selected from H, a C1-C5 alkyl group, and Sι(R') 3 where R' is independently selected from H, and a C1 -C5 alkyl group R 2 is independently selected from H, a C1 -C5 aSkyl group, and NR 1 R", where R' and R" are independently selected from C1 -C5 aikyl groups L is a neutral ligand (e g

THF, diethylether, triglyme, tetraglyme, etc) The varsabie m is one of 1 , 2, 3, or 4, the variable n is one of 1 ,2,3, or 4, and the variable k is one of 0,1 , 2, 3, 4, or 5

Other embodiments of the current invention may include, without limitation, one or more of the following features the reactor is maintained at a temperature between about 100 0 C and 500 0 C, and preferably between about 15O 0 C and 350 0 C, - the reactor is maintained at a pressure between about 1 Pa and

10 5 Pa, and preferably between about 25 Pa and 10 3 PA, a reducing gas is introduced to the reactor and the reducing gas is reacted with at least part of the precursor, prior to or concurrently with the deposition of at least part of the precursor onto the substrate, the reducing gas is one of H 2 , NH 3 , SiH 4 , Si 2 H 6 , Si 3 H 8 , SiH 2 Me 2 , SiH 2 Et 2 , N{SιH 3 ) 3 , hydrogen radicals and mixtures thereof, an oxidizing gas is introduced to the reactor, and the oxidizing gas is reacted with at least part of the precursor, prior to or concurrently with the deposition of at least part of the precursor onto the substrate; the oxidizing gas is one of O 2 ; O 3 ; H 2 O; NO; oxygen radicals; and mixtures thereof; the deposition process is a chemical vapor deposition ("CVD") type process or an atomic layer deposition ("ALD") type process, and either may be plasma enhanced; the precursor is synthesized according to at least one synthesis scheme; the precursor is a nicke! containing precursor selected from: (cyclopentadieny!)-(bis-isopropylacetamidinate)-nickei; (methylcyclopentadienyl)-(bis-isopropylacetamidinate)-nickel ; (ethyfcyc[opentadienyl)-(bis-isopropylacetamidinate)-nickel;

(isopropylcyclopentadienyl)-(bis-isopropy!acetamidinate)- nickel; (tetramethyicyclopentadienyl)-(bis-isopropylacetamidinate)- nickel; (cyclopentadienylHmethyl-isopropylacetamidinate)- nickel; (methylcyclopentadienyi)-(methyl- isopropylacetamidinate)-nickel; (ethylcyclopentadienyl)-(methyl- isopropylcetamidinate)-nicke!; (cyc!opentadienyl)-(methyl- ethylacetamidinate)-nickel; (methylcyclopentadienyl)-(methyl- ethylacetamidinate)-nickel; (ethylcyclopentadienyl)-(methyl- ethylacetamidinate)~nickel; (cyclopentadienyl)-(bis- isopropylformamidinate)-nickel; (methylcyciopentadienyl)-(bis- isopropylformamidinate)-nickel; and (ethylcyclopentadienyl)- (bis-isopropylformamidinate)-nickel; the precursor is a cobalt containing precursor selected from: (cyc!opentadienyl)-(bis-isopropylacetamidinate)-cobalt; (methylcyc!opentadienyl)"(bis-isopropylacetamidinate)-cobalt ;

(ethylcyclopentadienyl)-(bis-isopropylacetamidinate)-coba lt; (isopropy!cyclopentadienyl)~(bis-isopropylacetamidinate)-cob alt; (tetramethylcyclopentadienylHbis-isopropylacetamidinate)- cobalt, (cyclopentadienyiHmethyi-fsopropylacetamidinate)- cobait, (methylcyclopeπtadιenyl)-(methyl- ιsopropylacetamιdιnate)-cobalt, (ethylcyclopentadieny!)-(methyl- isopropylcetam!dinate)-cobalt, (cycSopentadιeny!)-(methyJ- ethylacetamιdinate)-cobalt, (methylcyclopentadienyl)-(methyl- ethylacetamιdinate)-cobalt, (ethylcyclopentadιenyl)-(methyl- eihylacetamιdinate)-cobait, (cyciopentadιenyi)-(bιs- ιsopropylformamιdιnate)-cobalt, (methylcyclopentadιenyi)-(bιs- ιsopropylformamιdιnate)-cobatt, and (ethylcyclopentadienyl)-

(bιs-ιsopropylformamιdιnate)-cobait, and the precursor is a ruthenium containing precursor selected from (cyclopentadιenyl)-(bιs-ιsopropylacetamιdιnate)- ruthenium, (methylcyclopentadienyl)-(bis- ιsopropy!acetamidιnate)-ruthenιum, (ethylcyclopentadieny!)-

(bιs-ιsopropyiacetamιdιnate)-ruthenιum, (isopropylcyclopentadienylHbis-isopropylacetamidinate)- ruthenium, (tetramethylcyclopentadιenyl)-(bιs- ιsopropylacetamidιnate)-ruthenιum, (cyc!opentadιenyl)~(methyi- isopropylacetamidinatej-ruthenium, (methylcyclopentadsenyS)-

(methyl-ιsopropylacetamιdιnate)-ruthenιum, (ethylcyclopentadienylHmethyl-isopropylcetamidinate)- ruthenium, (cyclopentadienyO-tmethyl-ethylacetamidinate)- ruthenium, (methyicyciopentadιenyl)-(methyl- ethylacetamιd!nate)-ruthenιum, (ethylcyclopentadienyl)-(methyl- ethylacetamιdinate)-ruthenιum, (cyclopentadιenyl)-(bιs- ιsopropylformamιdιnate)-ruthen!um, (methylcyclopentadieny!)- (bis-isopropylformamidinatej-ruthenium, and (ethyicyciopentadienylHbis-isopropylformamidinateJ-ruthenium

The foregoing has outlined rather broadly the features and technical advantages of the present invention in order that the detailed description of the invention that follows may be better understood. Additional features and advantages of the invention will be described hereinafter that form the subject of the claims of the invention. It should be appreciated by those skilled in the art that the conception and the specific embodiments disclosed may be readily utilized as a basis for modifying or designing other structures for carrying out the same purposes of the present invention. It should also be realized by those skilled in the art that such equivalent constructions do not depart from the spirit and scope of the invention as set forth in the appended claims.

Notation and Nomenclature

Certain terms are used throughout the following description and claims to refer to various components and constituents. This document does not intend to distinguish between components that differ in name but not function.

Generally as used herein, elements from the periodic table have been abbreviated according to their standard abbreviation (e.g. Ru = ruthenium, Co = cobalt, Ni = nickel, etc).

As used herein, the term "alkyl group" refers to saturated functional groups containing exclusively carbon and hydrogen atoms. Further, the term

"alkyl group" may refer to linear, branched, or cyclic alkyl groups. Examples of linear alkyl groups include without limitation, methyl groups, ethyl groups, propyl groups, butyl groups, etc, Examples of branched alkyis groups include without limitation, f-butyi. Examples of cyclic alkyl groups include without limitation, cyclopropyl groups, cyclopentyl groups, cyclohexyl groups, etc.

As used herein, the abbreviation, "Me," refers to a methyi group; the abbreviation, "Et," refers to an ethyl group; the abbreviation, "t-Bu," refers to a tertiary butyl group; the abbreviation "iPr", refers to an isopropyi group; the abbreviation "acac", refers to acetylacetonato; and the abbreviation "Cp" refers to a cyclopentadienyi group.

As used herein, the term "independently" when used in the context of describing R groups should be understood to denote that the subject R group is not only independently selected relative to other R groups bearing the same or different subscripts or superscripts, but is also independently selected relative to any additional species of that same R group. For example in the formula MR 1 X (NR 2 R 3 ) (4-X) , where x is 2 or 3, the two or three R 1 groups may, but need not be identical to each other or to R 2 or to R 3 .

Further, it should be understood that unless specifically stated otherwise, values of R groups are independent of each other when used in different formuias.

Description of Preferred Embodiments

Embodiments of the present invention provide novel methods and compositions useful for the deposition of a film on a substrate. Methods to synthesize these compositions are also provided. In general, the disclosed compositions and methods utilize a heteroleptic metal precursor.

Generally, the combination of a cyclopentadiene ligand with an amidinate ligand into a new heteroleptic metal precursor creates a new precursor having a lower melting point than the homoleptic parent. The new precursor is also more volatile and thermally more stable than the homoleptic parent.

Some embodiments of the invention reiate to a metal containing precursor, and methods for depositing a metal containing film with the precursor.

In these embodiments, the metal containing precursor has the general formula (1 )

wherein M is a metal selected from v among the^ elements Mn, Fe, Ni, Co, Pd, Pt, Ag, Au, Ru 1 Os, Rh, Ir, and Re, and preferably, M is selected from the elements Ni 1 Co, and Ru. (R 1 -N-C^)=N-Rs) is an amidine or guanidine ligand (preferably bis isopropyiacetamidinate where R 1 = R 3 = isopropyl and R 2 = methyl), and (R 4 R 5 R 6 RyReCp) is a, substituted or unsubstituted, cyclopentadienyl iigand (preferably methylcyclopentadienyl, wherein R 4 = Me and R 5 = R 6 = R7 =Rs = H; or tetramethylcyclopentadienyl, wherein R 4 = H and R 5 = Re = R7 =Rs = Me) . Each of Ri, R 3 , R 4 , Rs, Re, R7, and R 8 are independently selected from H, a C1-C5 a!ky! group, and Si(R 1 ^ where R' is independently selected from H, and a C1-C5 a!ky! group. R 2 is independently selected from H, a C1-C5 alkyl group, and NR'R", where R 1 and R" are independently selected from C1 -C5 alkyl groups. L is a neutral ligand (e.g.

THF 1 diethylether, triglyme, tetraglyme, etc). The variable m is one of 1 , 2, 3, or 4, and preferably is 1 ; the variable n is one of 1 ,2,3, or 4, and is preferably 1 ; and the variable k is one of 0,1 , 2, 3, 4, or 5, and is preferably 0.

In some embodiments, these precursors exhibit properties making desirable for use in deposition type process (e.g. CVD, ALD, etc). Desirable properties of the metal precursors for these applications include, i) liquid form or low melting point solid at room temperature More preferably the precursor will be in a liquid form during the deposition process (i.e at process conditions); ii) high volatility, in) sufficient thermal stability to avoid decomposition during handling and delivery; iv) appropriate reactivity during

CVD/ALD process.

in some embodiments, the first metal precursor may be one of the following precursors, which are shown structurally below also (2) (cyciopentadienylHbis-isopropylacetamidinate)-nickel,

(3) (methylcyclopentadιenyl)-(bιs-ιsopropylacetamιdιnate)-n ιckel,

(4) (ethylcyclopentadιenyl)-(bιs-isopropylacetamιdιnate)~nι ckei;

(5) (ιsopropylcyclopentadienyl)-(bis-isopropylacetamidιnate)-n ickel;

(6) (tetramethylcyc!opentadιenyl)-(bιs-ιsopropylacetamιdinat e)-nickei; (7) (cyclopentadienyl)-(methyl-isopropyiacetamidinate)-nicke!;

(8) (methylcyclopentadienyl)-(methyl-ιsopropylacetamιdinate)-n ιckel; (9) (ethylcyclopentadieny])-{methyl-isopropylcetamidinate)-nicke l, (10) (cyclopentadienyl)-(methyl-ethylacetamidinate)-nickei;

(11 ) (methylcyclopentadienylHmethy!-ethy!acetamidinate)-nickel; {12) (ethyScyclopentadieny!)-(methyl-ethylacetamidinate)-nickel; (13) {cyclopentadienylHbis-isopropylformamidinate^nickel; (14) {methylcyc[opeπtadiθny!)-(bis-isopropylformamidinate)-nick el; (15) (ethylcyciopentadienylHbis-isopropylformamidinateJ-nickel;

_ |Pr

(2) (3) f (_4n) (5) (6}

O Et

^SS^

Ni Ni Ni / \

,Pr-N N-Me ,Pr-M 7 \. Me ^ \ Me

T

(7) (8) (9)

(10) (1 1) ( 12 )

,Pr N^N Me |Pr N ^ N Me iRr ^ \ . Me

(13) (14) ( 15)

(16) (cyclopentadienyi)-(bis-isopropylacetamidinate)-cobalt; (17) (methylcyclopentadienyl)"(bιs-isopropyiacetam!dιnate)- cobalt;

(18) (ethylcyclopentadienylj-fbis-isopropylacetamidinate)- cobalt;

(19) (isopropylcyciopentadienyl)-(bis-isopropylacetamidinate)- cobalt; (20) {tetramethylcyclopentadienyl)-(bis-tsop(Opylacetamtdinate)- cobalt; (21 ) (cyclopentadienylHmethyi-isopropylacetamidinate)- cobalt; (22) (methylcyclopentadienylHmethyl-isopropylacetamidinatθ)- cobalt;

(23) (ethylcyciopentadienylHmethyl-isopropylcetamidinate)- cobalt;

(24) (cyclopentadienylHmethyl-ethylacetamidinate)- cobalt; (25) (methyicyclopentadienyl)-(methyl-θthy!acetamidinate)- cobait;

(26) (ethylcyclopentadienySHmethyl-ethylacetamidinate)- cobalt;

(27) (cyclopentadienylHbis-isopropylformamidinate)- cobait;

(28) (methylcyclopentadienyl)-(bis-isopropylforrnamid!nate)- cobalt;

(29) (ethylcyclopentadienylHbis-isopropylfoirnamidinate)- coba!t;

-sPr

(16) (17) (18) (19) (20)

(21) (22) (23)

, Eϊ

Co

/ \ Co Co

Et N N Me I \ I \

Et N jti Me Et-N N-Me

(24) (25) T

(26)

(27) (28) (29)

(30) (cyclopentadienyl)-(b)s-isopropylacetamidinate)-ruthenium;

(31 ) (methylcyciopentadienylHbis-isopropylacetamidinate)- ruthenium;

(32) (ethyicyclopentadienylHbis-isopropylacetamidinate)- ruthenium; (33) (isopropylcyclopentadienyiHbis-isopropylacetamidinate)- ruthenium;

(34) (tetramethylcyclopentadienylXbis-isopropylacetamidinate)- ruthenium;

(35) (cyclopentadienylj-fmethyl-isopropylacetamidinate)- ruthenium;

(36) (methylcyclopentadienylHmethyl-isopropylacetamidinate)- ruthenium;

(37) (ethylcyclopentadienyiHmethyl-isopropylcetamidinate)- ruthenium; (38) (cycfopentadienylj^methyl-ethylacetamidinate)- ruthenium;

(39) (methylcyciopentadienylHmethyl-ethylacetamidinate)- ruthenium,

(40) (ethylcyclopentadienyiHrnethyl-ethylacetamidinate)- ruthenium; (41 ) (cyclopentadienyl)-(bis-fsopropylformamidinate)- ruthenium;

(42) (methylcyclopentadienylHbis-isopropylformamidinate)- ruthenium; (43) (ethy!cyciopentadienyl)-(bis-isopropylformamidinate)- ruthenium.

l Pr lPr iPr-N "V ^ ^ N-ιPr

(30) (31) {32) (33) (34)

^ L ; RU RU iPr-N N Me |Pr _ N X N _ Me |Rr ^ \ Me

T V -V

(35) (36) (37)

(38) (39) (40)

(41 ) (42) (43)

Some embodiments of the present invention describe the synthesis of a heteroleptic amidinate(or guanidinate) / cyciopentadienyl metal precursor, in order to prepare a liquid or a low melting point solid metal precursor, volatile and suitable for ALD process. In some embodiments, the molecular formula is:

(1 ) WI(RrN-C(Rz)=N-R 3 UR 4 R 5 R 6 R 7 R 8 Cp) 1n LK; wherein M is a metal selected from among the elements Mn 5 Fe, Ni, Co, Pd, Pt, Ag, Au, Ru, Os, Rh, Ir, and Re, and preferably, M is selected from the elements Ni, Co, and Ru. (R 1 -N-C(R 2 )^N-R 3 ) is an amidine or guanidine ligand (preferably bis isopropylacetamidinate where Ri = R 3 = isopropyl and R 2 = methyl), and (R 4 R 5 R 6 R 7 RsCp) is a, substituted or unsubstituted, cyclopentadienyl ligand (preferably methyicyclopentadienyl, wherein R 4 = methyl and R 5 = Re = R7 =Rs = H; or tetramethylcyclopentadienyl, wherein R 4 = H and R 5 = R 6 = R? =Rs = methyl) . Each of R 1 , R 3 , R4, R5. Re, R/, and R 8 are independently selected from H, a C1-C5 alkyi group, and Si(R') 3 , where R 1 is independently selected from H, and a C1-C5 alky! group. R 2 is independentiy selected from H, a C1-C5 alkyl group, and NR 1 R", where R J and R" are independentiy selected from C1-C5 alkyl groups. L is a neutral ligand (e.g. THF, diethylether, triglyme, tetraglyme, etc). The variable m is one of 1 , 2, 3, or 4, and preferably is 1 ; the variable n is one of 1 ,2,3, or 4, and is preferably 1 ; and the variable k is one of 0,1 , 2, 3, 4, or 5, and is preferably 0.

Some embodiments describe The synthesis of M(RrN-C(R 2 )^N- , which may be carried out by the following methods"

Method A: By reacting [M(R 4 R 5 ReRyRsCp) n IXnQ j Jp (where X = Cl, Br or I; Q is a neutral ligand (PPh 3 for instance); j, p, and k are independently selected from 0 to 5; and m and n are independently selected from 1 to 4) with n equivalents of N(RrN-C(R 2 J=N-R 3 ) (Scheme-1 ), where N = Li, Na, K.

Methods B1 & B2

- Method B1 By reacting M(R 4 R 5 R 6 R 7 R 8 Cp) m +n (where m and n are independently selected from 1 to 4, and k is independently selected from 0 to 5) with n equivalent N(R r N-C(R 2 )=N-R 3 ) (Scheme-2), where N = H, Li, Na, K

Scheme-2-1

- Method B2 By reacting M(Ri-N-C(R2)=N-R3)m +n (where m and n are independently selected from 1 to 4, and k is independently selected from 0 to 5) with m equivalent of N(R 4 R 5 R 6 R 7 RgCp) (Scheme-2-2), where N = H, Li, Na 1 K

Methods C1 & C2 - Method C1 in-situ reacting [MX m+n ] p (where X = Cl 1 Br 1 I, j, p, and k are independently selected from 0 to 5, and m and n are independently selected from 1 to 4) (in a stepwise reaction without isolation of intermediate products) with m equivalent of N(R 4 R 5 R 6 R 7 RsCp) (where N = Li Na, K) eventually under reflux eventually followed by filtration, and reacting the filtrate with n equivalent of N(R 1 -N-C(R 2 J=N-R 3 ) (where N = Li, Na, K) (Scheme-3-1 ) Scheme-3-1

- Method C2: in-situ reacting MX m÷π (where X = Cl, Br, !; j, p, and k are independently selected from 0 to 5; and m and n are independently selected from 1 to 4) (in a stepwise reaction without isolation of intermediate products) with n equivalent of (where N = Li, Na, K) eventually under reflux, eventually followed by filtration, and reacting the filtrate with m equivalent of N(R 4 R 5 ReR 7 RsCp) (where N = Li, Na, K) (Scheme-3-2).

Scheme-3-2

The precursor can be delivered in neat form or in a blend with a suitable solvent: preferably Ethyl benzene, Xylenes, Mesitylene, Decane, Dodecane in different concentrations.

In some embodiments, the present invention also describes the method for depositing a film containing metal using the precursors with general molecular formula, (1 ) In some embodiments, the deposited films will the general formula IV

M k SIi 1 M n O m or M x NyO z ., where k, 1, m, n, x, y range from 1 to 6.

The disclosed precursors may be deposited to form a thin film using any deposition methods known to those of skill in the art. Examples of suitable deposition methods include without limitation, conventional CVD, low pressure chemical vapor deposition (LPCVD), plasma enhanced chemical vapor depositions (PECVD), atomic layer deposition (ALD), pulsed chemical vapor deposition (P-CVD) 1 plasma enhanced atomic layer deposition (PE- ALD), or combinations thereof.

In an embodiment, the first precursor is introduced into a reactor in vapor form. The precursor in vapor form may be produced by vaporizing a liquid precursor solution, through a conventional vaporization step such as direct vaporization, distillation, or by bubbling an inert gas (e.g. N 2 , He, Ar, etc.) into the precursor solution and providing the inert gas plus precursor mixture as a precursor vapor solution to the reactor. Bubbling with an inert gas may also remove any dissolved oxygen present in the precursor solution. The reactor may be any enclosure or chamber within a device in which deposition methods take place such as without limitation, a cold-wall type reactor, a hot-wall type reactor, a single-wafer reactor, a multi-wafer reactor, or other types of deposition systems under conditions suitable to cause the precursors to react and form the layers.

Generally, the reactor contains one or more substrates on to which the thin films wil! be deposited. The one or more substrates may be any suitable substrate used in semiconductor, photovoltaic, fiat panel or LCD-TFT device manufacturing. Examples of suitable substrates include without limitation, silicon substrates, silica substrates, silicon nitride substrates, silicon oxy nitride substrates, tungsten substrates, or combinations thereof. Additionally, substrates comprising tungsten or noble metals (e.g. platinum, palladium, rhodium or gold) may be used. The substrate may also have one or more layers of differing materials already deposited upon it from a previous manufacturing step.

In some embodiments, in addition to the first precursor, a reactant gas may also be introduced into the reactor. In some of these embodiments, the reactant gas may be an oxidizing gas such as one of oxygen, ozone, water, hydrogen peroxide, nitric oxide, nitrogen dioxide, radical species of these, as well as mixtures of any two or more of these. In some other of these embodiments, the reactant gas may be a reducing gas such as one of hydrogen, ammonia, a silane (e.g. SiH 4 ; Si 2 H 61 Si 3 H 8 ), SiH 2 Me 2 ; SiH 2 Et 2 ; N(SiH 3 ) 3 ; radical species of these, as well as mixtures of any two or more of these. In some embodiments, and depending on what type of film is desired to be deposited, a second precursor may be introduced into the reactor. The second precursor comprises another metai source, such as copper, praseodymium, manganese, ruthenium, titanium, tantalum, bismuth, zirconium, hafnium, lead, niobium, magnesium, aluminum, lanthanum, or mixtures of these, in embodiments where a second metal containing precursor is utilized, the resultant film deposited on the substrate may contain at least two different metal types.

The first precursor and any optional reactants or precursors may be introduced sequentially (as in ALD) or simultaneously (as in CVD) into the reaction chamber. In some embodiments, the reaction chamber is purged with an inert gas between the introduction of the precursor and the introduction of the reactant. in one embodiment, the reactant and the precursor may be mixed together to form a reactant/precursor mixture, and then introduced to the reactor in mixture form, in some embodiments, the reactant may be treated by a plasma, in order to decompose the reactant into its radical form. In some of these embodiments, the plasma may generally be at a location removed from the reaction chamber, for instance, in a remotely located plasma system, in other embodiments, the plasma may be generated or present within the reactor itself. One of skill in the art would generally recognize methods and apparatus suitable for such plasma treatment.

Depending on the particular process parameters, deposition may take place for a varying length of time. Generally, deposition may be allowed to continue as long as desired or necessary to produce a film with the necessary properties. Typical film thicknesses may vary from several hundred angstroms to several hundreds of microns, depending on the specific deposition process. The deposition process may also be performed as many times as necessary to obtain the desired film.

In some embodiments, the temperature and the pressure within the reactor are held at conditions suitable for ALD or CVD depositions. For instance, the pressure in the reactor may be heid between about 1 Pa and about 10 5 Pa, or preferably between about 25 Pa and 10 3 Pa 1 as required per the deposition parameters. Likewise, the temperature in the reactor may be held between about 100° C and about 500° C, preferably between about 150° C and about 350° C. In some embodiments, the precursor vapor solution and the reaction gas, may be pulsed sequentially or simultaneously (e.g. pulsed CVD) into the reactor. Each pulse of precursor may last for a time period ranging from about 0.01 seconds to about 10 seconds, alternatively from about 0.3 seconds to about 3 seconds, alternatively from about 0.5 seconds to about 2 seconds. !n another embodiment, the reaction gas, may also be pulsed into the reactor. In such embodiments, the pulse of each gas may last for a time period ranging from about 0.01 seconds to about 10 seconds, alternatively from about 0.3 seconds to about 3 seconds, alternatively from about 0.5 seconds to about 2 seconds.

EXAMPLES

The following non-limiting examples are provided to further illustrate embodiments of the invention. However, the examples are not intended to be all inclusive and are not intended to limit the scope of the inventions described herein.

Example 1

Synthesis of (cyclopentadienyl)-(bis-isopropylacetamidinate)-nickel In 10OmL schlenk flask, 0.974 g (7.716 mmol) of bisisopropylcarbodiimide were introduced with 10 mL of THF. MeLi (1.6 M in ether) 4.82 mL (7.716 mmol) was introduced dropwise at -78 0 C. A white precipitate was formed, it was allowed to warm up to room temperature for 1 hour ("h). To this first soiution 1.0 g (7.716 mmoi) of NiCI 2 was added. It was refluxed at 6O 0 C under stirring for 16 h. Color slowly turned to dark brown. LiCp 555 mg (7.716 mmol) was then introduced and the final solution allowed to react 1 night (approx 12 hours) at room temperature. Color turned to dark green. Solvent was removed under vacuum and pentane added (20 mL). The solution was filtered over celite and the celite washed with pentane (10 mL). Pentane was removed under vacuum to give a dark green sticky solid It was sublimed at 40 0 C / 10 mTorr to give a dark green sticky solid, 665 mg (35 %) 1 H NMR C 6 D 6 δppm= 8.0 (s, 2H), 3.49 (s, 3H), 0 91 (s, 12H), 0.12 (s, 5H),

MP=13 °C.

Example 2

Synthesis of {methylcyclopentadienylHbis-ϊsopropyiacetamidinate)- nickel

In 10OmL schlenk flask 0 974 g (7.716 mmol) of bisisopropylcarbodiimide were introduced with 10 mL of THF MeLi (1 6 M in ether) 4.82 mL (7.716 mmol) was introduced dropwise at -78 C. A white precipitate was formed. It was allowed to warm up to room temperature for 1 h. To this first solution 1 0 g (7 716 mmol) of NiCI 2 was added, it was refluxed at 60 ° C under stirring for 16 h. Color slowly turned to dark brown LiIvIeCp 664 mg (7.716 mmoi) was then introduced and the final soiution allowed to react for 1 night (approx. 12 hours) at room temperature Color turned to dark green. Solvent were removed under vacuum and pentane added (20 mL) The solution was filtered over celite and the celite washed with pentane (10 mL) Pentane was removed under vacuum to give a dark green liquid It was distillated at 100 ° C / 20 mTorr to give a dark green liquid, 1 27 g (59 %) 1 H NMR C 6 D 6 δppm= 9.52 (s, 2H), 9.04 (s, 3H), 4.21 (s, 3H), 1 0 (s, 12H), -1.73 (s, 2H), -1.90 (s, 2H) MP=9 * C Example 3

Synthesis of (ethyicyclopentadienylHbis-isopropylacetamidinate)- nickel in 10OmL schienk flask 1.948 g (15.431 mmol) of bisisopropyicarbodiimide were introduced with 20 ml_ of THF. MeLi (1.6 M in ether) 9 64 mL (15.431 mmol) was introduced dropwise at -78 C. A white precipitate was formed, it was allowed to warm up to room temperature for 1 h. To this first solution 2.0 g (15.431 mmol) of NiCi 2 was added It was refiuxed at 60 °C under stirring for 16 h Color slowiy turned to dark brawn LiEtCp 1 544 g (15 431 mmol) was then introduced and the final solution allowed to react 1 night (approx 12 hours) at room temperature Color turned to dark green. Solvent were removed under vacuum and pentane added (20 mL) The solution was filtered over celite and the cehte washed with pentane (10 mL). Pentane was removed under vacuum to give a dark green liquid. It was distiliated at 100-110 °C / 14 mTorr to give a dark green liquid, 1.24 g (27

%) 1 H NMR C 6 D 6 δppm= 10.02 (s, 2H), 9 08 (s, 2H), 4.42 (s, 3H), 1 84 (s, 3H), 1 02 (S 1 12H), -2.15 (s, 2H), -2 46 (s, 2H)

Example 4 Synthesis of (cyciopentadienyl)-(bis-isopropylacetamidinate)-cobalt

In 10OmL schienk 1.943 mg (15 4 mmo!) of bisisopropyicarbodiimide were introduced with 10 mL of THF MeLi (1 6 M in ether) 9 625 mL (15 4 mmol) was added dropwise at -78 "C It was allowed to react 1 h at room temperature To this first solution CoCI 2 was added 2 0 g (15 4 mmol) Color turned to dark green It was refiuxed at 80 C under stirring for 5 h NaCp

1 360 mg (15 4 mmol) was introduced and the final solution allowed to stir 1 night (approx 12 hours) at room temperature Color rapidly turned to dark red/brown Solvents were removed under vacuum and pentane added (20 mL) The solution was filtered over celite and pentane removed under vacuum to give a dark red/brown liquid it was distilled at 100 ° C / 6 mTorr

(bp^ 65 C@ 6 mTorr) to give a dark red liquid 1 850 g (45 %) 1 H NMR C 6 D 6 όppm= 4 33 (s, 12H), -23 53 (s, 5H), -51 04 (s, 2H), -69 89 (s, 3H) MP=7 0 C Example 5

PEALD experiments on Siθ 2 using (methylcyclopentadienyl)-(bis- isopropyiacetamidinate)-nickel.

Various depositions {PEALD type) were performed, with this molecule, the results of which are shown below.

Film Sheet

Type of

Run# T, 0 C Reductant thickness, resistivity, Comments experiment

A μΩ » cm

Ni 99 %+, Carbon at

275 H 2 PEALD 180 2000 detection limit Good surface

320 H 2 PEALD 250 80 coverage, very low carbon content

3 320 H2+NH3 PEALD 600 75 low carbon content

Therm CVD

No decomposition

4 320 (SeIf- 35 0 up to 320 0 C decomp.)

5 220 H 2 CVD 0 No deposition

6 275 H 2 CVD 20

7 275 H 2 CVD 110 1040

Example 6 PEALD experiments on SiO 2 using (cyclopentadienyl)-(bis- isopropylacetamidinate)-cobalt

Various depositions (PEALD type) were performed, with this molecule, the results of which are shown below. Fiim Sheet

Type of

Run# T, 0 C Reductant thickness, resistivity, Comments experiment

A μΩ » cm

Good surface

1 250 NH 3 PEALD 250 140 coverage

Good surface

2 200 NH 3 PEALD 190 150 coverage

Good surface

3 100 NH 3 PEALD 130 145 coverage

While embodiments of this invention have been shown and described, modifications thereof can be made by one skilled in the art without departing from the spirit or teaching of this invention. The embodiments described herein are exemplary only and not limiting. Many variations and modifications of the composition and method are possible and within the scope of the invention. Accordingly the scope of protection is not limited to the embodiments described herein, but is only limited by the claims which foilow, the scope of which shail include all equivalents of the subject matter of the claims.